A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
Determine the predictive value of CARDIOLITE® rest and stress myocardial perfusion imaging
(MPI) to define a pediatric population with Kawasaki Disease (KD) at high and low risk of
developing cardiac events.